ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,576.57
0.27%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Esperion Therapeutics Inc (ESPR)

  7. Esperion Therapeutics Inc (ESPR) 뉴스

ESPR Esperion Therapeutics Inc

1.90
-0.09 (-4.52%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Esperion Therapeutics Inc ESPR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.09 -4.52% 1.90 13:00:10
개장가 저가 고가 종가 전일 종가
2.01 1.88 2.01 1.90 1.99
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202421:00GLOBEEsperion to Report First Quarter 2024 Financial Results on..
08/04/202403:45GLOBEEsperion Presents Important New Data from CLEAR Outcomes at..
01/04/202421:00GLOBEEsperion to Ring Nasdaq Opening Bell Today, April 1, 2024
26/03/202421:00GLOBEEsperion to Participate in 23rd Annual Needham Virtual..
26/03/202405:00GLOBEEsperion Announces Data from CLEAR Outcomes Sub-Groups as..
23/03/202407:26BWU.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL®..
23/03/202404:10GLOBEU.S. FDA Approves Broad New Labels for NEXLETOL® and..
23/03/202400:04GLOBECHMP Issues Positive Opinions For Both Bempedoic Acid And..
27/02/202423:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202421:23EDGAR2Form 8-K - Current report
27/02/202420:00GLOBEEsperion Reports Fourth Quarter and Full Year 2023 Financial..
17/02/202406:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
15/02/202404:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202400:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202420:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202422:00GLOBEEsperion to Report Fourth Quarter and Full Year 2023..
02/02/202404:00GLOBERFK, Esperion Therapeutics Announce 2024 Promotional..
24/01/202406:00GLOBEEsperion Announces Closing of Public Offering of Common..
22/01/202420:10EDGAR2Form 8-K - Current report
22/01/202420:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/01/202411:15GLOBEEsperion Announces Pricing of $85.1 Million Public Offering..
19/01/202406:03EDGAR2Form 8-K - Current report
19/01/202406:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/01/202406:00GLOBEEsperion Announces Proposed Public Offering of Common Stock
12/01/202406:09EDGAR2Form 8-K - Current report
04/01/202405:15BWEsperion e Daiichi Sankyo Europe annunciano un emendamento..
04/01/202403:54BWEsperion et Daiichi Sankyo Europe annoncent une révision de..
04/01/202400:07BWEsperion und Daiichi Sankyo Europe geben Anpassung ihrer..
03/01/202422:00EDGAR2Form 8-K - Current report
03/01/202421:00BWEsperion and Daiichi Sankyo Europe Announce $125 Million..
18/12/202322:00GLOBEEsperion to Participate in 42nd Annual J.P. Morgan..
14/12/202306:46DJNEsperion Therapeutics' Nexletol, Nexlizet Updates Get FDA..
14/12/202306:00GLOBEU.S. FDA Updates LDL-C Lowering Indication for Esperion’s..
14/11/202300:30GLOBEEsperion Presents CLEAR Outcomes Analysis of Inflammation as..
12/11/202301:00GLOBEPartners Announce TRANSFORM Trial to Evaluate Personalized..
10/11/202306:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
07/11/202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:30EDGAR2Form 8-K - Current report
07/11/202320:00GLOBEEsperion Reports Third Quarter 2023 Financial Results
31/10/202321:00GLOBEEsperion to Participate in Jefferies London Healthcare..
24/10/202321:00GLOBEEsperion to Report Third Quarter 2023 Financial Results on..
05/10/202322:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/09/202306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/09/202304:22EDGAR2Form 144 - Report of proposed sale of securities
12/09/202323:15GLOBEAmerican College of Cardiology Program to Increase..
28/08/202321:00GLOBEEsperion to Participate in H.C. Wainwright 25th Annual..
27/08/202300:00GLOBEEsperion Presents Two CLEAR Outcomes Study Late-Breakers at..
24/08/202322:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/08/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
ESPR
Esperion Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유